First person gets new experimental vaccine for Ebola
Clinical trials for a new vaccine targeting the Bundibugyo ebolavirus have officially commenced following the administration of the first dose.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
The first volunteer has received an experimental vaccine as part of the world's first clinical trial for a Bundibugyo ebolavirus vaccine. This development is managed by the University of Oxford, according to coverage from the university and BBC News.
Reports from Forbes, CIDRAP, and Medical Xpress highlight the broader context of vaccine efficacy, noting that existing licensed vaccines for Zaire ebolavirus may offer partial protection against other strains. CIDRAP notes that current vaccines are capable of inducing antibody responses against the virus currently linked to an outbreak in Congo.
Coverage does not yet specify the anticipated duration of the trial or the timeline for preliminary results. Monitoring will continue regarding the vaccine's specific effectiveness against the Bundibugyo strain compared to existing licensed options.
Synthesized by Archynetys from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 17m ago.
Quick answers
What is the focus of the new vaccine trial?
The trial is testing the world's first vaccine specifically targeting the Bundibugyo ebolavirus.
Do existing vaccines work against this strain?
According to coverage, licensed Zaire ebolavirus vaccines may offer partial protection, and existing vaccines induce an antibody response against the virus driving the current Congo outbreak.
Who is leading the new trial?
The University of Oxford is conducting the trial.
Coverage (5)
- New Ebola Vaccine Enters Human Clinical Trials Forbes · 10h ago
- Licensed Zaire Ebola vaccine may offer partial protection against Bundibugyo outbreak Medical Xpress · 10h ago
- First volunteer vaccinated in the world's first Bundibugyo ebolavirus vaccine trial University of Oxford · 10h ago
- Existing vaccines induce antibody response against the Ebola virus that's driving Congo outbreak CIDRAP · 10h ago
- First person gets new experimental vaccine for Ebola BBC · 10h ago
Topics
Related trends
‘There’s no salary’: DRC health workers tell of hardship as Ebola spreads
An Ebola outbreak in the Democratic Republic of Congo has surpassed 1,000 deaths, with health workers warning of critical resource shortages.
‘We Will All Die From Ebola Here’: Virus Stalks Crowded Camps in Congo
An Ebola outbreak in the DR Congo has surpassed 1,000 deaths, described as the fastest-ever instance of the virus.
Pancreatic cancer vaccine shows promise in first human trial, preventing disease in high-risk patients
A first-in-human trial for a mutant KRAS vaccine shows promise in preventing pancreatic cancer among high-risk patients.
At least 930 people have died in Congo's Ebola outbreak
An Ebola outbreak in the Democratic Republic of Congo has resulted in nearly 1,000 deaths as confirmed cases continue to rise.
Ebola death toll rises to 930, as outbreak spreads at record pace
The Ebola death toll in the DR Congo has reached 930 as the outbreak spreads at a record pace.
Canada to temporarily bar entry for foreigners who have recently been to Congo, against UN advice
5 news sources are covering this World story right now — Archynetys is tracking how fast it spreads.